by EmpathiCSubstanceS | May 2, 2018 | Anxiety
phosphorloxy-N,N-dimethyltryptamine (psilocybin) and methylenedioxymethamfetamine (MDMA), best known for their illegal use as psychedelic drugs, are showing promise as therapeutics in a resurgence of clinical research during the past 10 years. Psilocybin is being...
by EmpathiCSubstanceS | May 2, 2018 | Addiction, Anxiety
It hurts to be left out, but for most people, social exclusion doesn’t become pathological. For people with depression, anxiety or other mental health issues, though, it can be a huge problem, worsening symptoms and creating a feedback loop of negativity. Enter...
by EmpathiCSubstanceS | May 2, 2018 | Anxiety, Depression
Researchers’ long fight to test psilocybin’s safety finally yields fruit. A hallucinogenic drug derived from magic mushrooms could be useful in treating depression, the first safety study of this approach has concluded. Researchers from Imperial College...
by EmpathiCSubstanceS | May 2, 2018 | Addiction, Anxiety
hree years later Daniel Kreitman still chokes up when he talks about what he saw, and how it changed him. Kreitman, an upholsterer by trade, had taken psilocybin, a hallucinogen derived from mushrooms, in a trial at Johns Hopkins University School of Medicine for...
by EmpathiCSubstanceS | May 2, 2018 | Addiction, Anxiety
Patients unresponsive to conventional treatments benefit when treated with natural psychoactive compound, but researchers warn against self medication. Magic mushrooms may effectively “reset” the activity of key brain circuits known to play a role in depression, the...
